- Home
- TUYA vs CGEM Comparison
TUYA vs CGEM Comparison
Compare TUYA & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUYA
- CGEM
- Stock Information
- Founded
- TUYA 2014
- CGEM 2016
- Country
- TUYA China
- CGEM United States
- Employees
- TUYA N/A
- CGEM N/A
- Industry
- TUYA Computer Software: Prepackaged Software
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- TUYA Technology
- CGEM Health Care
- Exchange
- TUYA Nasdaq
- CGEM Nasdaq
- Market Cap
- TUYA 1.6B
- CGEM 530.0M
- IPO Year
- TUYA 2021
- CGEM 2021
- Fundamental
- Price
- TUYA $2.44
- CGEM $7.68
- Analyst Decision
- TUYA
- CGEM Strong Buy
- Analyst Count
- TUYA 0
- CGEM 6
- Target Price
- TUYA N/A
- CGEM $28.17
- AVG Volume (30 Days)
- TUYA 1.9M
- CGEM 350.6K
- Earning Date
- TUYA 08-25-2025
- CGEM 08-07-2025
- Dividend Yield
- TUYA 2.48%
- CGEM N/A
- EPS Growth
- TUYA N/A
- CGEM N/A
- EPS
- TUYA 0.03
- CGEM N/A
- Revenue
- TUYA $311,642,000.00
- CGEM N/A
- Revenue This Year
- TUYA $11.65
- CGEM N/A
- Revenue Next Year
- TUYA $13.06
- CGEM N/A
- P/E Ratio
- TUYA $75.16
- CGEM N/A
- Revenue Growth
- TUYA 27.64
- CGEM N/A
- 52 Week Low
- TUYA $1.28
- CGEM $6.85
- 52 Week High
- TUYA $4.63
- CGEM $21.01
- Technical
- Relative Strength Index (RSI)
- TUYA 48.87
- CGEM 45.96
- Support Level
- TUYA $2.42
- CGEM $7.29
- Resistance Level
- TUYA $2.59
- CGEM $7.94
- Average True Range (ATR)
- TUYA 0.10
- CGEM 0.39
- MACD
- TUYA 0.01
- CGEM -0.01
- Stochastic Oscillator
- TUYA 59.72
- CGEM 61.01
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, it has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.